General Information of Drug-Metabolizing Enzyme (DME ID: DME0538)
DME Name Cyclic ADP-ribose hydrolase 1 (CD38), Homo sapiens DME Info
UniProt ID
CD38_HUMAN
EC Number    EC: 3.2.2.6     (Click to Show/Hide the Complete EC Tree)
Hydrolases
Glycosylase
N-Glycosyl compound glycosidase
EC: 3.2.2.6
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification Healthy
               ICD-11: Healthy Click to Show/Hide the Full List of HOSPPI:        2 HOSPPI
                     Transcription-factor regulation
                            Proto-oncogene c-Myc (MYC) Health Activation
Uniprot ID
MYC_HUMAN
Interaction Name MYC-CD38 interaction [2]
Studied Cell Lines EREB2-5 cell line
Ensembl ID
ENSG00000136997
Description Proto-oncogene c-Myc (MYC) is reported to activate the transcription of CD38 gene, which leads to an increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between MYC and CD38 can activate the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
                     Non-coding RNA regulation
                            hsa-miR-140-3p Health Suppression
miRBase ID
MIMAT0004597
Interaction Name hsa-miR-140-3p--CD38 regulation [1]
Studied Cell Lines Airway smooth muscle cells
Description hsa-miR-140-3p is reported to suppress CD38 mRNA translation by binding to the 3' untranslated region (3'UTR) of CD38 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1.
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2A00 Brain cancer Click to Show/Hide the Full List of HOSPPI:        9 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Glioblastoma Moderate hypomethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 2.72E-06; delta-beta: -2.14E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the CD38 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can moderatly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Central neurocytoma Moderate hypomethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 2.46E-06; delta-beta: -2.95E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the CD38 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can moderatly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Cerebral hemispheric glioma Moderate hypomethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 8.50E-06; delta-beta: -2.45E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the CD38 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can moderatly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Melanocytoma Significant hypermethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypermethylation
p-value: 3.71E-10; delta-beta: 3.11E-01
Description DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CD38 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can significantly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Myxopapillary ependymoma Significant hypomethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 4.53E-13; delta-beta: -3.22E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the CD38 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can significantly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Cerebellar liponeurocytoma Significant hypomethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 1.60E-06; delta-beta: -4.04E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the CD38 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can significantly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Third ventricle chordoid glioma Moderate hypomethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 3.76E-04; delta-beta: -2.68E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the CD38 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can moderatly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Spinal ependymoma Significant hypomethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 6.25E-18; delta-beta: -3.83E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the CD38 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can significantly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Oligodendroglioma Significant hypermethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypermethylation
p-value: 2.70E-23; delta-beta: 3.14E-01
Description DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CD38 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can significantly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2A83 Multiple myeloma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Histone modification
                            Histone deacetylases (HDACs) Multiple myeloma Repression
Uniprot ID
HDAC1_HUMAN
Interaction Name HDACs-CD38 interaction [3]
Studied Cell Lines Multiple myeloma cell line
Description Histone deacetylases (HDACs) are reported to deacetylate the CD38 gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between HDACs and CD38 can inhibit the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
               ICD-11: 2B30 Lymphoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Lymphoma Significant hypomethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 2.83E-26; delta-beta: -3.59E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the CD38 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can significantly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2B71 Gastric cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Gastric cancer Moderate hypermethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Adjacent Tissue Moderate hypermethylation
p-value: 3.11E-02; delta-beta: 2.21E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the CD38 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can moderatly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2C30 Melanoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Melanoma Moderate hypermethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypermethylation
p-value: 1.68E-04; delta-beta: 2.50E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the CD38 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can moderatly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2D50 Brain cancer metastasis Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Posterior fossa ependymoma Moderate hypomethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 2.78E-35; delta-beta: -2.65E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the CD38 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can moderatly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2E06 Prostate cancer metastasis Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Prostate cancer metastasis Significant hypermethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypermethylation
p-value: 3.55E-05; delta-beta: 3.98E-01
Description DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CD38 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can significantly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
      ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases
               ICD-11: 5B81 Obesity Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Obesity Significant hypermethylation
Interaction Name DNMT-CD38 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypermethylation
p-value: 5.85E-14; delta-beta: 3.88E-01
Description DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the CD38 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Cyclic ADP-ribose hydrolase 1. As a result, the interaction between DNMT and CD38 can significantly affect the drug-metabolizing process of Cyclic ADP-ribose hydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
References
1 miR-140-3p regulation of TNF-alpha-induced CD38 expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2012 Sep;303(5):L460-8.
2 Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells. Int J Cancer. 2001 Sep;93(6):810-6.
3 Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab. Leukemia. 2020 Apr 29.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.